First Use of DFINE’s STAR System for Spinal Tumors a Success

DFINE, a San Jose, Calif.-based medical device company, announced the first patient was treated successfully with its Spinal Tumor Ablation with Radiofrequency System.

Advertisement

The system is a targeted radiofrequency ablation device that delivers energy directly into a metastatic vertebral body tumor to heat and destroy tumor cells and provide palliative pain relief. The system was developed specifically for treating patients with spinal tumors.

The first procedure was performed at the University of Louisville Hospital/James Graham Brown Cancer Center. The company expects the system to become fully commercially available later this year.


Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!

More Articles on Orthopedic Surgery:
25 Orthopedic Surgeons on the Move

Why to Consider Partial Knee Replacements: Q&A With Dr. Craig Della Valle of Midwest Orthopaedics at Rush

Cleveland Clinic, Media Hospital Open $2.2M Orthopedic and Spine Center

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.